NCT06975072View on ClinicalTrials.gov

Effect of Magnesium on Neuromonitoring

PHASE4RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
SpinePainSpine SurgerySpine Surgery With NeuromonitoringSpine Surgery With Motor Evoked Potential MonitoringSpine Fusion
Interventions
DRUG

Magnesium sulfate administration

A single intravenous bolus of Mg of 30mg/kg (based on ideal body weight) will be administered over a period of 10 minutes (min).

Trial Locations (1)

94143

RECRUITING

University of California San Francisco Hospital, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER